David G Brauer1, Matthew S Strand1, Dominic E Sanford1, Vladimir M Kushnir2, Kian-Huat Lim2, Daniel K Mullady2, Benjamin R Tan2, Andrea Wang-Gillam2, Ashley E Morton2, Marianna B Ruzinova3, Parag J Parikh4, Vamsi R Narra5, Kathryn J Fowler5, Majella B Doyle1, William C Chapman1, Steven S Strasberg1, William G Hawkins1, Ryan C Fields6. 1. Department of Surgery, Barnes-Jewish Hospital and the Alvin J. Siteman Cancer Center at Washington University School of Medicine, Saint Louis, MO, USA. 2. Department of Medicine, Barnes-Jewish Hospital and the Alvin J. Siteman Cancer Center at Washington University School of Medicine, Saint Louis, MO, USA. 3. Department of Pathology and Immunology, Barnes-Jewish Hospital and the Alvin J. Siteman Cancer Center at Washington University School of Medicine, Saint Louis, MO, USA. 4. Department of Radiation Oncology, Barnes-Jewish Hospital and the Alvin J. Siteman Cancer Center at Washington University School of Medicine, Saint Louis, MO, USA. 5. Mallinckrodt Institute of Radiology, Barnes-Jewish Hospital and the Alvin J. Siteman Cancer Center at Washington University School of Medicine, Saint Louis, MO, USA. 6. Department of Surgery, Barnes-Jewish Hospital and the Alvin J. Siteman Cancer Center at Washington University School of Medicine, Saint Louis, MO, USA. Electronic address: fieldsr@wudosis.wustl.edu.
Abstract
BACKGROUND & OBJECTIVES: Multidisciplinary tumor boards (MDTBs) are frequently employed in cancer centers but their value has been debated. We reviewed the decision-making process and resource utilization of our MDTB to assess its utility in the management of pancreatic and upper gastrointestinal tract conditions. METHODS: A prospectively-collected database was reviewed over a 12-month period. The primary outcome was change in management plan as a result of case discussion. Secondary outcomes included resources required to hold MDTB, survival, and adherence to treatment guidelines. RESULTS: Four hundred seventy cases were reviewed. MDTB resulted in a change in the proposed plan of management in 101 of 402 evaluable cases (25.1%). New plans favored obtaining additional diagnostic workup. No recorded variables were associated with a change in plan. For newly-diagnosed cases of pancreatic ductal adenocarcinoma (n = 33), survival time was not impacted by MDTB (p = .154) and adherence to National Comprehensive Cancer Network guidelines was 100%. The estimated cost of physician time per case reviewed was $190. CONCLUSIONS: Our MDTB influences treatment decisions in a sizeable number of cases with excellent adherence to national guidelines. However, this requires significant time expenditure and may not impact outcomes. Regular assessments of the effectiveness of MDTBs should be undertaken.
BACKGROUND & OBJECTIVES:Multidisciplinary tumor boards (MDTBs) are frequently employed in cancer centers but their value has been debated. We reviewed the decision-making process and resource utilization of our MDTB to assess its utility in the management of pancreatic and upper gastrointestinal tract conditions. METHODS: A prospectively-collected database was reviewed over a 12-month period. The primary outcome was change in management plan as a result of case discussion. Secondary outcomes included resources required to hold MDTB, survival, and adherence to treatment guidelines. RESULTS: Four hundred seventy cases were reviewed. MDTB resulted in a change in the proposed plan of management in 101 of 402 evaluable cases (25.1%). New plans favored obtaining additional diagnostic workup. No recorded variables were associated with a change in plan. For newly-diagnosed cases of pancreatic ductal adenocarcinoma (n = 33), survival time was not impacted by MDTB (p = .154) and adherence to National Comprehensive Cancer Network guidelines was 100%. The estimated cost of physician time per case reviewed was $190. CONCLUSIONS: Our MDTB influences treatment decisions in a sizeable number of cases with excellent adherence to national guidelines. However, this requires significant time expenditure and may not impact outcomes. Regular assessments of the effectiveness of MDTBs should be undertaken.
Authors: Rozh Jalil; Waseem Akhter; Benjamin W Lamb; Cath Taylor; Jenny Harris; James S A Green; Nick Sevdalis Journal: J Urol Date: 2014-03-11 Impact factor: 7.450
Authors: Brendan C Visser; Yifei Ma; Yulia Zak; George A Poultsides; Jeffrey A Norton; Kim F Rhoads Journal: HPB (Oxford) Date: 2012-06-12 Impact factor: 3.647
Authors: Henner M Schmidt; John M Roberts; Artur M Bodnar; Sonia Kunz; Steven H Kirtland; Richard P Koehler; Michal Hubka; Donald E Low Journal: Ann Thorac Surg Date: 2015-02-10 Impact factor: 4.330
Authors: Chien-Hsin Chen; Mao-Chih Hsieh; Wilson T Lao; En-Kwang Lin; Yen-Jung Lu; Szu-Yuan Wu Journal: Am J Cancer Res Date: 2018-09-01 Impact factor: 6.166
Authors: Kyle Scarberry; Lee Ponsky; Edward Cherullo; William Larchian; Donald Bodner; Matthew Cooney; Rodney Ellis; Gregory Maclennan; Ben Johnson; William Tabayoyong; Robert Abouassaly Journal: Can Urol Assoc J Date: 2018-05-14 Impact factor: 1.862
Authors: Christopher Noda; Gregory A Williams; Gretchen Foltz; Hyun Kim; Dominic E Sanford; Chet W Hammill; Ryan C Fields Journal: J Surg Oncol Date: 2020-07-13 Impact factor: 2.885
Authors: John M David; Sungjin Kim; Veronica R Placencio-Hickok; Arman Torosian; Andrew Hendifar; Richard Tuli Journal: Adv Radiat Oncol Date: 2018-11-09
Authors: Ashika D Maharaj; Jennifer F Holland; Ri O Scarborough; Sue M Evans; Liane J Ioannou; Wendy Brown; Daniel G Croagh; Charles H C Pilgrim; James G Kench; Lara R Lipton; Trevor Leong; John J McNeil; Mehrdad Nikfarjam; Ahmad Aly; Paul R Burton; Paul A Cashin; Julie Chu; Cuong P Duong; Peter Evans; David Goldstein; Andrew Haydon; Michael W Hii; Brett P F Knowles; Neil D Merrett; Michael Michael; Rachel E Neale; Jennifer Philip; Ian W T Porter; Marty Smith; John Spillane; Peter P Tagkalidis; John R Zalcberg Journal: BMJ Open Date: 2019-09-30 Impact factor: 2.692
Authors: Haneen A AlFarhan; Ghada F Algwaiz; Hajer A Alzahrani; Roaa S Alsuhaibani; Ashwaq Alolayan; Nafisa Abdelhafiz; Yosra Ali; Sami Boghdadly; Abdul Rahman Jazieh Journal: J Glob Oncol Date: 2018-09
Authors: Mohammed Basendowah; Alaa M Awlia; Hanin A Alamoudi; Hala M Ali Kanawi; Abdulaziz Saleem; Nadim Malibary; Hussam Hijazi; Mohammed Alfawaz; Anas H Alzahrani Journal: Cancer Rep (Hoboken) Date: 2021-03-19